Paravertebral Block to Reduce the Incidence of New Onset Atrial Fibrillation After Cardiac Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

April 9, 2021

Primary Completion Date

July 8, 2025

Study Completion Date

July 8, 2025

Conditions
New Onset Atrial FibrillationAnesthesia, LocalCardiac Disease
Interventions
DRUG

Ropivacaine 0.2% Injectable Solution

Patients in the intervention group will have ultrasound guided bilateral T3 paravertebral catheters placed prior to surgery. Prior to surgery, these patients will have 5ml of 1.5% lidocaine with 1:200,000 epinephrine injected in each catheter. Ropivacaine 0.2% will be administered via programmed intermittent bolus of 7ml every 60 minutes through each catheter during and after surgery.

Trial Locations (1)

55455

University of Minnesota, Minneapolis

All Listed Sponsors
lead

University of Minnesota

OTHER